Virtus ETF Advisers’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-58,544
| Closed | -$283K | – | 495 |
|
|
2020
Q1 | $283K | Sell |
58,544
-4,940
| -8% | -$23.9K | 0.12% | 233 |
|
|
2019
Q4 | $675K | Buy |
63,484
+14,578
| +30% | +$155K | 0.11% | 158 |
|
|
2019
Q3 | $509K | Sell |
48,906
-8,221
| -14% | -$85.6K | 0.1% | 180 |
|
|
2019
Q2 | $875K | Buy |
57,127
+30,273
| +113% | +$464K | 0.18% | 161 |
|
|
2019
Q1 | $345K | Sell |
26,854
-2,869
| -10% | -$36.9K | 0.73% | 47 |
|
|
2018
Q4 | $282K | Buy |
29,723
+2,982
| +11% | +$28.3K | 0.05% | 135 |
|
|
2018
Q3 | $444K | Sell |
26,741
-19,109
| -42% | -$317K | 0.05% | 143 |
|
|
2018
Q2 | $736K | Sell |
45,850
-5,828
| -11% | -$93.6K | 0.65% | 79 |
|
|
2018
Q1 | $791K | Buy |
51,678
+27,720
| +116% | +$424K | 0.69% | 75 |
|
|
2017
Q4 | $374K | Buy |
+23,958
| New | +$374K | 0.47% | 68 |
|